Blue Sky Specialty Pharmacy, a leading innovator in the Specialty Pharmacy space, announced recently that they have just received the coveted URAC designation status pursuant to Rare Disease – Center of Excellence, Accreditation. URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations … Read more
Health care consulting leader Monument Analytics announces that it has changed its name to Stage Analytics™. The new name captures the importance of Stage’s work, and it reflects the firm’s ongoing commitment to making a difference in the world by impacting every stage of life. Stage Analytics is committed to providing the highest quality scientific … Read more
Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products, today announced the acquisition of MIDI Labs and MIDI, Inc., both headquartered in Newark, Delaware. Biolog and MIDI serve many of the same customers and industries. Over the last two decades, both companies have served the microbial ID community, offering complimentary products and … Read more
Form Bio, the breakthrough computational life sciences platform, today announced the integration of the NVIDIA Clara Parabricks suite of genomic analysis tools with Form Bio’s genomic analysis workflows. The integrated solution, provided by Form Bio, enables scientists, bioinformaticians, and other life science professionals to execute genomic workflows with acceleration fueled by GPU parallelization and deep learning … Read more
Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which are mood altering but non-hallucinogenic. Recently, Gb Sciences received positive preclinical results supporting the efficacy of its proprietary kava-based formulas designed for the treatment of … Read more
Iberfar Indústria Farmacêutica S.A (“Iberfar”), a Portuguese Pharmaceutical Group operating a state-of-the-art manufacturing facility near Lisbon, and Herbolea Biotech SpA (“Herbolea”), an Italian biotech company that licenses proprietary technologies for solvent-free extraction of botanicals, are pleased to announce the signing of a Licensing Agreement granting Iberfar the rights to utilize Herbolea’s extraction and purification technologies in Portugal. … Read more
Lifecycle Compliance announces the establishment of Lifecycle Labs to meet the growing North Carolina demand for professional microbiology services in the pharmaceutical, biotechnology and healthcare industries. Lifecycle Labs headquarters are located at 7020 Kit Creek Road, Morrisville, North Carolina, and specializing in providing environmental monitoring services, including but not limited to: environmental monitoring (EM) plates … Read more
According to Levin Health, a sports science company focused on researching, developing and commercialising a range of medicinal cannabis products such as CBD oil Australia wide, research into medicinal cannabis has uncovered a clear movement away from illicit use to legal use. People using cannabis for health reasons prefer the layer of safety that comes with … Read more
Germfree, a Florida based company, is introducing its new line of aseptic PEC (primary engineering control) equipment at the ASHP Midyear Clinical Meeting in Las Vegas. The newly redesigned equipment includes Laminar Flow Hoods, Biological Safety Cabinets, and Cleanroom Pass-Through Boxes. These new products build on Germfree’s 60 years of aseptic PEC expertise in both the … Read more
Nemysis Ltd today announces a Strategic Cooperation with Faran S.A., a leading Greek pharma company, for the development and later commercialization of its E40 endopeptidase as a novel enzymatic therapy for gluten degradation. “Faran has a longstanding tradition in bringing to the Greek market innovative products and providing innovative solutions to tackle highly prevalent unmet … Read more
